Japan Cell Culture Protein Surface Coatings Market Size & Outlook
Japan cell culture protein surface coatings market, 2018-2030 (US$M)
Related Markets
There are two acts for regulation of regenerative medicine and cell therapy in Japan—The Act on the Safety of Regenerative Medicine (ASRM) and the Act on Pharmaceutical and Medical Devices (PMD Act). These two laws were enacted in November 2014. Two laws introduced in Japan in 2014 offer a fast track to the market for stem-cell-based treatments and other types of regenerative medicine. The Act on the Safety of Regenerative Medicine allows operating players to register a therapy under one of three risk categories. Furthermore, it allows clinics and hospitals to commercialize cellular therapies without going through the usual kinds of trials to prove that a medicine is effective. It is mandatory for a hospital to have a cell-processing facility certified by the Ministry of Health, Labor and Welfare to offer cellular therapies. In addition, The Pharmaceutical and Medical Devices Act permits for conditional approval of therapies that have gone through some clinical testing. Companies are given the chance to promote a treatment across the country and get insurance payments, but they are also required to gather additional efficacy data over a 7-year period.cell culture protein surface coatings market highlights
- The Japan cell culture protein surface coatings market generated a revenue of USD 35.3 million in 2023 and is expected to reach USD 118.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 18.8% from 2024 to 2030.
- In terms of segment, self-coating was the largest revenue generating coating type in 2023.
- Pre-coating is the most lucrative coating type segment registering the fastest growth during the forecast period.
Cell culture protein surface coatings market data book summary
| Market revenue in 2023 | USD 35.3 million |
| Market revenue in 2030 | USD 118.1 million |
| Growth rate | 18.8% (CAGR from 2023 to 2030) |
| Largest segment | Self-coating |
| Fastest growing segment | Pre-coating |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Self-coating, Pre-coating |
| Key market players worldwide | Thermo Fisher Scientific Inc, Corning Inc, Merck KGaA, Eppendorf, Sartorius AG, PerkinElmer, Greiner Bio-One, ZenBio, Kollodis BioSciences, Viogene Biotek |
Other key industry trends
- In terms of revenue, Japan accounted for 3.7% of the global cell culture protein surface coatings market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China cell culture protein surface coatings market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 229.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell Culture Protein Surface Coatings Market Scope
Cell Culture Protein Surface Coatings Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan cell culture protein surface coatings market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell culture protein surface coatings market will help companies and investors design strategic landscapes.
Self-coating was the largest segment with a revenue share of 62.61% in 2023. Horizon Databook has segmented the Japan cell culture protein surface coatings market based on self-coating, pre-coating covering the revenue growth of each sub-segment from 2018 to 2030.
There are two acts for regulation of regenerative medicine and cell therapy in Japan—The Act on the Safety of Regenerative Medicine (ASRM) and the Act on Pharmaceutical and Medical Devices (PMD Act). These two laws were enacted in November 2014. Two laws introduced in Japan in 2014 offer a fast track to the market for stem-cell-based treatments and other types of regenerative medicine.
The Act on the Safety of Regenerative Medicine allows operating players to register a therapy under one of three risk categories. Furthermore, it allows clinics and hospitals to commercialize cellular therapies without going through the usual kinds of trials to prove that a medicine is effective.
It is mandatory for a hospital to have a cell-processing facility certified by the Ministry of Health, Labor and Welfare to offer cellular therapies. In addition, The Pharmaceutical and Medical Devices Act permits for conditional approval of therapies that have gone through some clinical testing.
Reasons to subscribe to Japan cell culture protein surface coatings market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan cell culture protein surface coatings market databook
-
Our clientele includes a mix of cell culture protein surface coatings market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan cell culture protein surface coatings market , including forecasts for subscribers. This country databook contains high-level insights into Japan cell culture protein surface coatings market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan cell culture protein surface coatings market size, by coating type, 2018-2030 (US$M)
Japan Cell Culture Protein Surface Coatings Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
